Cholinergic afferents suppress basolateral amygdala output through muscarinic receptors and feed-forward inhibition
(A) Schematic of injection strategy to express ChR2 in cholinergic neurons of the basal forebrain (BF) and eYFP in GABAergic neurons of the BLA (BLAGABA), using conditional viral expression in ChAT::Cre x VGAT::Flpo mice (VGAT = vesicular GABAergic transporter), along with CTB-647 as a retrograde marker of neurons projecting to dmPFC.
(B) Confocal image of the BLA showing whole-cell patch-clamp recording arrangement in the BLA with optical stimulation of ChR2-expressing BF terminals. AP coordinate = -1.58.
(C) High magnification images of neurobiotin-filled recorded BLA neurons expressing CTB-647 (BLA-mPFC; upper panels) and eYFP (BLAGABA, lower panels).
(D) Passive membrane properties of BLA-mPFC and BLAGABA neurons. BLA-mPFC neurons had significantly greater capacitance (unpaired t-test: t42=11.90, ***p<0.001, n=20 BLA-mPFC, n=24 BLAGABA, from 9 mice), smaller membrane resistance (unpaired t-test: t42=6.326, ***p<0.001, n=20 BLA-mPFC, n=24 BLAGABA, from 9 mice), and more negative resting membrane potential (unpaired t-test: t29=2.857, **p=0.0078, n=13 BLA-mPFC, n=18 BLAGABA, from 8 mice) than BLAGABA neurons.
(E) Example trace and frequency histogram showing suppression of firing in BLA-mPFC neurons and facilitation of firing of BLAGABA neurons following optical stimulation of cholinergic terminals (470 nm light, 20 Hz; scale bars=20 mV, 5 s).
(F) Membrane potential of BLA-mPFC (upper traces) and BLAGABA neurons (lower traces) in response to 1 s 470 nm light delivered at 5, 10, and 20 Hz in current-clamp.
(G) At each stimulation frequency the amplitude of the fast excitatory postsynaptic potential (EPSP) was greater in BLAGABA neurons (green) compared with BLA-mPFC neurons (magenta; 2-way ANOVA, main effect of cell type: F1,40=95.59, ***p<0.001; n=7, 7, 15 BLA-mPFC neurons at 5, 10, 20 Hz, n=5, 5, 7 BLAGABA neurons at 5, 10, 20 Hz, from 9 mice), while the slower inhibitory postsynaptic current (IPSP) was greater in BLA-mPFC neurons (2-way ANOVA, main effect of cell type: F1,40=47.29, ***p<0.001; n=7, 7, 15 BLA-mPFC neurons at 5, 10, 20 Hz, n=5, 5, 7 BLAGABA neurons at 5, 10, 20 Hz, from 9 mice).
(H) Response of BLA-mPFC (upper traces) and BLAGABA neurons (lower traces) to a single 5 ms pulse of 470 nm light, with application of TTX/4AP to isolate monosynaptic currents.
(I) Following application of TTX/4AP, the EPSP was maintained in BLAGABA neurons (green; unpaired t-test: t15=0.367, p=0.719, n=8 (ACSF) and n=9 (TTX/4AP) BLAGABA cells from 4 mice), while the IPSP was maintained in BLA-mPFC neurons (magenta; unpaired t-test: t16=0.094, p=0.926, n=9 (ACSF) and n=9 (TTX/4AP) BLA-mPFC cells from 3 mice).
(J) Example traces showing inhibition of the IPSP in BLA-mPFC neurons (upper panels) by the muscarinic receptor antagonist scopolamine (10 µM) (dark gray), but not nicotinic antagonists (dihydro-ß-erythroidine 10 µM, methyllycaconitine 0.1 µM, mecamylamine 10 µM) (light gray), and inhibition of the EPSP in BLAGABA neurons (lower panels) by nicotinic receptor antagonists, but not muscarinic.
(K) Proposed circuit model showing BF inhibition of BLA output by ACh acting at nicotinic receptors on BLAGABA neurons and muscarinic receptors on projection neurons. Dashed lines represent local BLAGABA neuron synapses onto BLA projector neurons from prior literature (Lee and Kim, 2019; Woodruff and Sah, 2007).